Hepion Pharmaceuticals, Inc.
Investing in early-stage biopharmaceutical companies can be both exciting and challenging. In this blog post, we take a deep dive into the 10-K filing of Hepion Pharmaceuticals, Inc., a company that has been in the spotlight for its work on rencofilstat, a cyclophilin inhibitor intended to treat ...